[HTML][HTML] Aspirin in Primary Prevention: Looking for Those Who Enjoy It
R Della Bona, S Giubilato, M Palmieri… - Journal of Clinical …, 2024 - mdpi.com
Based on a wealth of evidence, aspirin is one of the cornerstones of secondary prevention of
cardiovascular disease. However, despite several studies showing efficacy also in primary …
cardiovascular disease. However, despite several studies showing efficacy also in primary …
Aspirin in Primary Prevention: Looking for Who Enjoys It!
R Della Bona, S Giubilato, M Palmieri, S Benenati… - 2024 - preprints.org
Based on a wealth of evidence, aspirin is one of the cornerstones of secondary prevention of
cardiovascular disease. However, despite several studies showing efficacy also in primary …
cardiovascular disease. However, despite several studies showing efficacy also in primary …
Lipoprotein (a) kao misteriozni čimbenik kardiovaskularne bolesti
M Zelić - 2024 - repozitorij.mef.unizg.hr
Lipoprotein (a) je molekula slična LDL-u, za koju je specifičan dodatak glikoproteina
apolipoproteina (a). Apo (a) vrlo je polimorfan glikoprotein te interindividualne razlike u …
apolipoproteina (a). Apo (a) vrlo je polimorfan glikoprotein te interindividualne razlike u …
[HTML][HTML] Benefit of Aspirin Could Depend on Lipoprotein (a) Levels, Study Finds
P Campbell - hcplive.com
An analysis of more than 2900 people with a median follow-up of 26 years, results of the
study suggest regular aspirin use in those aged 40 to 70 years cut the risk of atherosclerotic …
study suggest regular aspirin use in those aged 40 to 70 years cut the risk of atherosclerotic …